Better Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Better Therapeutics

11/08/2022 14:33

* Better Therapeutics Inc  BTTX.OQ  reported a quarterly
adjusted
loss of 42 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 45 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Better Therapeutics Inc's reported EPS for the quarter was
a
loss of 42 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Better Therapeutics Inc shares had risen by 14.7% this
quarter and lost 61.5% so far this year.
    * The company reported a quarterly loss of $9.93 million.
    * Wall Street's median 12-month price target for Better
Therapeutics Inc is $15.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 01:33 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.45          -0.42          Beat
 Mar. 31 2022      -0.38          -0.41          Missed
 Dec. 31 2021      -0.46          -0.71          Missed
 Sep. 30 2021      -1.66          -0.03          Beat